This is a preview of subscription content, access via your institution
Access options
References
Hermiston ML, Xu Z, Weiss A . CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003; 21: 107–137.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.
Yeh SP, Chang JG, Lin CL, Lo WJ, Lee CC, Lin CY et al. Mesenchymal stem cells can be easily isolated from bone marrow of patients with various hematological malignancies but the surface antigens expression may be changed after prolonged ex vivo culture. Leukemia 2005; 19: 1505–1507.
Lichtenstein A, Berenson J, Norman D, Chang MP, Carlile A . Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood 1989; 74: 1266–1273.
Schwab J, Illges H . Regulation of CD21 expression by DNA methylation and histone deacetylation. Int Immunol 2001; 13: 705–710.
Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870–878.
Zhang FB, Li L, Fang B, Zhu DL, Yang HT, Gao PJ . Passage-restricted differentiation potential of mesenchymal stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 2005; 336: 784–792.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yeh, SP., Chang, JG., Lo, WJ. et al. Induction of CD45 expression on bone marrow-derived mesenchymal stem cells. Leukemia 20, 894–896 (2006). https://doi.org/10.1038/sj.leu.2404181
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404181